Home/Filings/4/0001123292-21-000085
4//SEC Filing

Myint Han 4

Accession 0001123292-21-000085

CIK 0001661059other

Filed

Jan 18, 7:00 PM ET

Accepted

Jan 19, 5:21 PM ET

Size

5.2 KB

Accession

0001123292-21-000085

Insider Transaction Report

Form 4
Period: 2021-01-13
Myint Han
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2021-01-13+200,000200,000 total
    Exercise: $12.09Exp: 2031-01-12Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]One fourth of the option vests on January 11, 2022. The remainder vests in 36 monthly installments beginning on February 11, 2022.

Issuer

NextCure, Inc.

CIK 0001661059

Entity typeother

Related Parties

1
  • filerCIK 0001840942

Filing Metadata

Form type
4
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 5:21 PM ET
Size
5.2 KB